Accès ouvert
2026
article
OpenAlex
Atsushi Mihara, Kiminori Yukata, Norihiro Nishida, Tetsuya Seto et autres
Anabolic agents such as parathyroid hormone (PTH) analogs and sclerostin antibody (Scl-Ab) enhance fracture healing through distinct mechanisms, but whether the order of administration affects healing remains unclear. In a murine tibial osteotomy model, we compared PTH monotherapy (40 μg/kg), Scl-Ab monotherapy …
jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Mitsuhiro Yamaguchi, Yukihiro Hitaka, Shunya Tsuji, Masashi Ogawa et autres
Kidney ischemia-reperfusion (I/R) injury is an unavoidable complication of kidney transplantation that contributes to acute kidney injury (AKI), chronic kidney disease (CKD), and limited long-term graft survival. Elevated serum phosphate has been implicated not only as a consequence of renal dysfunction but …
jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Shunya Tsuji, Sosuke Nakano, Koyu Ito, Shohei Minami et autres
Persistent hyposmia is a hallmark of post COVID-19 conditions, yet the mechanisms sustaining olfactory dysfunction after viral clearance remain poorly understood. Here, using mouse models of SARS-CoV-2 infection, we show that virus-induced senescence-like changes in uninfected olfactory mucosal fibroblasts persist long after …
jp
(code pays fourni par la source)
2026
article
OpenAlex
Francisco Triana-Martínez, Alessandra Pierantoni, Daisy Graça, Veronica Bergo et autres
fr, de, jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Sana Ando, Shunta Ikeda, Keiko Tanaka, Yuri Tomabechi et autres
The transcription factor c-Myc is a master oncoprotein that regulates over 15% of all genes. Protein phosphatase 2A (PP2A), a crucial tumor suppressor, destabilizes c-Myc protein. Classically, PP2A-mediated dephosphorylation of Ser62 followed by Thr58 phosphorylation was thought to promote ubiquitination of c-Myc …
jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Kazuya Uehara, Keiichi Katō, Shunya Tsuji, Kiminori Yukata et autres
Nontraumatic osteonecrosis of the femoral head (ONFH) is a progressive disorder marked by ischemic necrosis of subchondral bone, often leading to femoral head collapse. Although bisphosphonates effectively target osteoclasts in osteoporosis and show benefit in ONFH animal models, their effectiveness to prevent …
jp
(code pays fourni par la source)
2025
article
OpenAlex
Kazuya Uehara, Kiminori Yukata, Takashi Imagama, Shunya Tsuji et autres
jp
(code pays fourni par la source)
2025
article
OpenAlex
Tetsuya Seto, Kiminori Yukata, Zenzo Fujii, Masaaki Shibuya et autres
Chronic kidney disease (CKD) is associated with disturbances in bone and mineral metabolism, leading to osteoporosis and vascular calcification, which are significant contributors to mortality. Although denosumab, a monoclonal antibody targeting RANKL, has been shown to increase BMD, its effects on vascular …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shunta Ikeda, Sana Ando, Nana Kishida, Keiko Tanaka et autres
Protein methylesterase-1 (PME-1) is an essential enzyme that catalyzes the demethylation of protein phosphatases 2A (PP2A) and PP4 catalytic subunits to alter the composition of holoenzymes. Elevated PME-1 protein levels are observed in neurodegenerative diseases and cancer, suggesting the involvement of dysregulation …
jp
(code pays fourni par la source)
2025
article
OpenAlex
Shunta Ikeda, Sana Ando, Nana Kishida, Keiko Tanaka et autres
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shunya Tsuji, Akihiko Sakamoto, Kenji Takemoto, Tetsuya Seto et autres
Osteoclasts are specialized cells essential for bone resorption, a crucial process in bone remodeling, and dysregulation of osteoclastogenesis can lead to pathological bone loss such as osteoporosis and rheumatoid arthritis. Therefore, understanding the precise mechanisms governing osteoclast differentiation is crucial for developing …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ryoji Yanai, Genta Yasunaga, Shunya Tsuji, Takeshi Honda et autres
Age-related macular degeneration (AMD) is a leading cause of blindness in Western and developing countries. Since antivascular endothelial growth factor (VEGF) therapy is available for the regression of choroidal neovascularization (CNV), it does not work for the pathophysiology of AMD so a …
jp
(code pays fourni par la source)